Literature DB >> 16374012

New surgical technique for portal venous port system in Swine.

G M Kaiser1, N R Fruhauf, C E Broelsch.   

Abstract

The need for serial blood sampling and continuous infusion using the portal vein for experimental surgery and pharmacological studies is evident. As suitable animal models are rare, we established a new technique to implant a permanent vascular access device to the portal vein in swine. All operations in study animals (n=8) were technically feasible due to a regularly detected side branch of the portal vein within the inferior pancreatic region; complications did not occur. Mean operation time was 48+/-17 min. This study clearly shows that the portal venous access is feasible and can be achieved safely using the inferior pancreatic vein for a permanent vascular access port system. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16374012     DOI: 10.1159/000089241

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  3 in total

1.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

2.  Comparative Evaluation of Two Venous Sampling Techniques for the Assessment of Pancreatic Insulin and Zinc Release upon Glucose Challenge.

Authors:  Anil Kumar Pillai; William Silvers; Preston Christensen; Matthew Riegel; Beverley Adams-Huet; Ildiko Lingvay; Xiankai Sun; Orhan K Öz
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

3.  Porcine model for the study of liver regeneration enhanced by non-invasive 13C-methacetin breath test (LiMAx test) and permanent portal venous access.

Authors:  Eva-Maria Wittauer; Felix Oldhafer; Eva Augstein; Oliver Beetz; Moritz Kleine; Carsten Schumacher; Lion Sieg; Hendrik Eismann; Kai Johanning; André Bleich; Florian Wolfgang Rudolf Vondran
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.